Full Fiscal Year Pharmaceutical Software and Services up 13.8%, Fourth Quarter Revenues up 27.4%
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2014 Earnings Release and Conference Call
Conference Call to be on Tuesday, November 25, 2014, at 4:15 PM EST
Simulations Plus Announces Changes in Board of Directors
Dr. John Paglia, Ph.D., CFA, CPA to Replace Mr. Harold Wayne Rosenberger Retiring after 7 Years on Board
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
Cash dividend yield of 3.3% to be distributed in November
Simulations Plus Adds to Portfolio with Release of MembranePlus
First Release of New Product in 10 Years; Provides Unique In Vitro Permeability Capabilities and Creates Cross-Selling Opportunities
Simulations Plus Wins Cooperative Agreement with FDA
$200,000 Grant to Support Enhancements to Company’s Industry-Leading GastroPlus Software
Simulations Plus Releases GastroPlus Version 8.6
Interim release adds several user-requested functions
Simulations Plus Releases ADMET Predictor Version 7.1
Upgrade extends technological lead, adds several user-requested functions
Simulations Plus Announces Quarterly Cash Dividend
Cash dividend declared of $0.05 per share
Simulations Plus Provides Additional Details Regarding Cognigen Acquisition
Investor Conference Call Scheduled for Friday, July 25, at 1:15 PM PDT
Simulations Plus to Acquire Cognigen Corporation
A leading provider of clinical trial data analysis to expand company’s offerings
Simulations Plus Reports Third Quarter FY2014 Financial Results
Revenues up 20.9%, Net Income up 31.6%
Simulations Plus Sets Date for 3rd Quarter 2014 Earnings Release and Conference Call
Conference Call to be on Tuesday, July 8, at 4:15 PM ET
Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter FY2014
New All-time Record Revenues in Third Quarter
Simulations Plus Releases ADMET Predictor Version 7.0
Major upgrade improves all predictions, adds new ones